Infections due to Escherichia coli producing extended-spectrum β-lactamase among hospitalised patients: factors influencing mortality

Journal of Hospital Infection

Volumn 68, Issue 2, 2008, Pages 116-122

  Pena C ^a   Gudiol, C ^a   Calatayud, L ^a   Tubau, F ^a   Dominguez M A ^a   Pujol, M ^a   Ariza, J ^a   Gudiol, F ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Escherichia coli infections; Extended spectrum lactamase; Hospitalised patients; Mortality

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; MEROPENEM; TOBRAMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PERITONITIS; BACTERIAL STRAIN; CATHETER INFECTION; CHOLANGITIS; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG RESPONSE; DRUG TREATMENT FAILURE; ENZYME SYNTHESIS; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE INFECTION; GRAM NEGATIVE SEPSIS; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDY; RISK FACTOR; SOFT TISSUE INFECTION; STATISTICAL SIGNIFICANCE; SURGICAL INFECTION; SURVIVAL RATE; SURVIVOR; TREATMENT OUTCOME; URINARY TRACT INFECTION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; CASE-CONTROL STUDIES; COHORT STUDIES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN; TREATMENT OUTCOME; URINARY TRACT INFECTIONS;

EID: 39049155380     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2007.11.012     Document Type: Article

References (39)

1. Hyle E.P., Lipworth A.D., Zaoutis T.E., et al. Risk factors for increasing multidrug resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species. Clin Infect Dis 40 (2005) 1317-1324
2. Wiener J., Quinn J.P., Bradford P.A., et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. J Am Med Assoc 281 (1999) 517-523
3. Lautenbach E., Strom B.L., Bilker W.B., Patel J.B., Edelstein P.H., and Fishman N.O. Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis 33 (2001) 1288-1294
4. Schwaber M.J., Navon-Venezia S., Schwartz D., and Carmeli Y. High levels of antimicrobial coresistance among extended-spectrum beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 49 (2005) 2137-2139
5. Brun-Buisson C., Legrand P., Philippon A., Montravers F., Ansquer M., and Dural J. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet ii (1987) 302-306
6. Sirot J., Chanal C., Petit A., Sirot D., Labia R., and Gerbaud G. Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated beta-lactamases markedly active against third-generation cephalosporins: epidemiologic studies. Rev Infect Dis 10 (1988) 850-859
7. Rodriguez-Baño J., Navarro M.D., Romero L., et al. Clinical and molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implication for control. Clin Infect Dis 42 (2006) 37-45
8. Naas T., Philippon L., Poirel L., Ronco E., and Nordmann P. An SHV-derived extended-spectrum β-lactamase in Pseudomonas aeruginosa. Antimicrob Agents Chemother 43 (1999) 1281-1284
9. Cosgrove S.E., and Carmeli Y. The impact of antimicrobial resistance in health and economic outcomes. Clin Infect Dis 36 (2003) 1433-1437
10. Schwaber M.J., Navon-Venezia S., Kaye K.S., Ben-Ami R., Schwartz D., and Carmeli Y. Clinical and economic impact of bacteremia with extended-spectrum β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 50 (2006) 1257-1262
11. Ramphal R., and Ambrose P.G. Extended-spectrum β-lactamases and clinical outcomes: current data. Clin Infect Dis 42 (2006) S164-S172
12. Woodford N., Ward M.E., Kaufmann M.E., et al. Community and hospital spread Escherichia coli producing CTX-M extended-spectrum beta-lactamase in the U.K. J Antimicrob Chemother 54 (2004) 735-743
13. Rodriguez-Baño J., Navarro M.D., Romero L., et al. Epidemiology and clinical features of infections caused by extended-spectrum β-lactamase-producing Escherichia coli in non-hospitalized patients. J Clin Microbiol 42 (2004) 1089-1094
14. Peña C., Gudiol C., Tubau F., et al. Risk factors for acquisition of extended-spectrum β-lactamase-producing Escherichia coli among hospitalized patients. Clin Microbiol Infect 12 (2006) 279-284
15. Ben-Ami R., Schwaber M.J., Navon-Venezia S., et al. Influx of extended-spectrum β-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 42 (2006) 925-934
16. Calbo E., Romani V., Xercavins M., et al. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum β-lactamases. J Antimicrob Chemother 57 (2006) 780-783
17. Schiappa D.A., Hayden M.K., Matushek M.G., et al. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J Infect Dis 174 (1996) 529-536
18. Emery C.L., and Weymout H. Detection and clinical significance of extended-spectrum β-lactamase in tertiary-care medical center. J Clin Microbiol 35 (1997) 2061-2067
19. Paterson D.L., Ko W.C., Von Gottberg A., et al. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol 39 (2001) 2206-2212
20. Wong-Beringer A., Hindler J., Loeloff M., et al. Molecular correlations for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime. Clin Infect Dis 34 (2002) 135-146
21. Du B., Long Y., Liu H., et al. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome. Intensive Care Med 28 (2002) 1718-1725
22. Kim B.N., Woo J.H., Kim M.N., Ryu J., and Kim Y.S. Clinical implications of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteremia. J Hosp Infect 52 (2002) 99-106
23. Kim Y.K., Pai H., Lee H.J., et al. Bloodstream infections by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical results. Antimicrob Agents Chemother 46 (2002) 1481-1491
24. Ho P.T., Chan W.M., Tsang K.W.T., Wong S.S.Y., and Young K. Bacteremia caused by Escherichia coli producing extended-spectrum β-lactamase: a case-control study of risk factors and outcomes. Scand J Infect Dis 34 (2002) 567-573
25. Metan G., Zarakolu P., Çakir B., Hascelik G., and Uzun O. Clinical outcomes and therapeutics options of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli. Int J Antimicrob Agents 26 (2005) 254-257
26. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., and Hughes J.M. CDC definitions for nosocomial infections, 1988. Am J Infect Control 16 (1988) 128-140
27. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 15th edn. Approved standards M100-S14 (2005), Clinical and Laboratory Standards Institute, Wayne, PA
28. Legrand P., Fournier G., Bure A., et al. Detection of extended broad-spectrum beta-lactamases in Enterobacteriaceae in four French hospitals. Eur J Clin Microbiol Infect Dis 8 (1989) 527-529
29. Peña C., Pujol M., Ardanuy C., et al. An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum β-lactamase. J Hosp Infect 47 (2001) 53-59
30. Kang C.I., Kim S.H., Park W.B., et al. Bloodstream infections due to extended-spectrum Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. Antimicrob Agents Chemother 48 (2004) 4574-4581
31. Paterson D.L., Ko W.C., Gottberg A.V., et al. International prospective study of Klebsiella pneumoniae bacteremia: implication of extended-spectrum beta-lactamase production in nosocomial infections. Ann Intern Med 140 (2004) 26-32
32. Kang C.I., Sh K., Park W.B., et al. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcomes. Antimicrob Agents Chemother 49 (2005) 760-766
33. Hyle E.P., Lipworth A.D., Zaoutis T.E., Nachamkin I., Bilker W.B., and Lautenbach E. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae. Variability by site of infection. Arch Intern Med 165 (2005) 1375-1380
34. Lautenbach E., Patel J.B., Bilker W.B., Edelstein P.H., and Fishman N.O. Extended-spectrum β-lactamase-production Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 32 (2001) 1162-1171
35. Paterson D.L. Recommendations for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs). Clin Microbiol Infect 6 (2000) 460-461
36. Wong-Beringer A. Therapeutic challenges associated with extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae. Pharmacotherapy 21 (2001) 583-592
37. Meyer K.S., Urban C., Eagan J.A., and Berger B.J. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 119 (1993) 353-358
38. Falagas M.E., and Kopterides P. Risk factors for the isolation of multi-drug-resistant Acinetobacter baumanii and Pseudomonas aeruginosa: a systematic review of the literature. J Hosp Infect 64 (2006) 7-15
39. Paterson D.L. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis 43 (2006) S43-S48